PharmiWeb.com - Global Pharma News & Resources

Pharmacy - Press Releases

Date Title Company
27-Apr-2022 CD ComputaBio Unveils Protein Structure Modeling Service for Drug Development CD ComputaBio
26-Apr-2022 Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform Creative Proteomics
26-Apr-2022 Pronalyse Unveils Gene Therapy Products Characterization Service to Safely Accelerate Drug Development Creative Proteomics
26-Apr-2022 MicrobioSeq Division Releases Viral Metagenomics Services to Study Viruses CD Genomics
26-Apr-2022 MicrobioSeq Introduces Fungal Whole-Genome De Novo Sequencing Platform to Facilitate Microbial Research CD Genomics
26-Apr-2022 CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment CD Genomics
26-Apr-2022 World Malaria Day 2022 - Vestergaard CEO: Advance Equity. Build Resilience. End Malaria. Vestergaard
25-Apr-2022 Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022 Creative Enzymes
21-Apr-2022 REPORT CALLS FOR A NEW LEGAL FRAMEWORK FOR THE MANAGEMENT OF CONTROLLED DRUGS IN HOSPITALS SETTINGS Trinity PR
19-Apr-2022 Bora Pharmaceuticals to expand operations with $10m+ investment Bora Pharmaceuticals
13-Apr-2022 Pharmacy Automation Market Size is Going to Boom Development Growth, Research Scope and New Opportunities 2022 to 2030 Credible Markets
11-Apr-2022 Green Energy Market Revenue, Industry Size and Manufacturers Outlook | Top key players Tokyo Electric Power, Tata Power, RWE Group, Invenergy intelligence market report
06-Apr-2022 FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA SMi Group
06-Apr-2022 Early access issued for eligible patients in the UK for radioligand therapy in advanced prostate cancer Advanced Accelerator Applications (AAA), a Novartis company.
05-Apr-2022 NICE recommends Koselugo for the treatment of neurofibromatosis type 1 Syneos Health
05-Apr-2022 Omnicell Agree Product Distributor Agreement with Hanmi Pharm Omnicell International
04-Apr-2022 Symbiosis announces successful completion of UK Research and Innovation (UKRI) project, which will enhance the manufacturing supply chain for ATMPs within the UK Symbiosis
04-Apr-2022 Omnicell Agree Product Distributor Agreement with Hanmi Pharm Omnicell International
30-Mar-2022 Samsung Biologics holds 11th Annual General Meeting of Shareholders Samsung Biologics
30-Mar-2022 New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections Novartis